Deener: After three-year run, biotech stocks take a beating

Home › Deener: After three-year run, biotech stocks take a beating

Joel Roth, 65, of San Rafael, Calif., is taking Sovaldi for hepatitis c. It costs $1,000 per pill, or $84,000 for a 12-week treatment course.

05.10	Tropical Storm Milton Public Advisory Number 2
05.10	Hurricane Kirk Graphics
05.10	Hurricane Kirk Forecast Discussion Number 26
05.10	Tropical Storm Milton Graphics
05.10	Hurricane Kirk Wind Speed Probabilities Number 26
05.10	Hurricane Leslie Graphics
05.10	Hurricane Kirk Public Advisory Number 26
05.10	Summary for Hurricane Kirk (AT2/AL122024)
More »

je.st